Assay, B Lymphocyte Marker
A B lymphocyte marker assay is a laboratory hematology test used to identify and enumerate B lymphocytes by detecting characteristic cell-surface antigens, supporting the evaluation of humoral immunity, the diagnosis of B-cell lymphoproliferative disorders, and immune monitoring in transplantation. The device is FDA Class 2, indicating moderate risk and requiring 510(k) premarket clearance. It carries product code LJD and is regulated under 21 CFR 864.5220 within the Hematology specialty. This device is eligible for third-party review.
Research product code LJD in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- LJD
- Device Class
- FDA class 2
- Regulation Number
- 864.5220
- Medical Specialty
- Hematology
- Review Panel
- IM
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K851639 | ANTI-LEU-12 B CELL REAGENT | Jul 02, 1986 | Substantially Equivalent | Bd Becton Dickinson Vacutainer Systems Preanalytic |
FEI Numbers
This FDA classification entry is associated with 2 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 2 registration numbers. Click on an entry to view related FDA registrations.